期刊文献+

小儿CPB心内直视手术对胰岛素抵抗的影响 被引量:4

Insulin resistance during cardiac operations with cardiopulmonary bypass in children
在线阅读 下载PDF
导出
摘要 目的 :本研究旨在探讨CPB对激素、糖代谢和胰岛素抵抗的影响。方法 :19例先心病患儿分别在麻醉前、CPB前、CPB15min开放主动脉 5min、停机 2 0min采血测定血糖、胰岛素、C肽、生长激素和皮质醇 ,计算胰岛素敏感性指数和胰岛素血糖比。结果 :CPB期胰岛素、生长激素和皮质醇浓度较CPB前有显著增高 ;血糖、C肽和胰岛素血糖比也有类似变化 ,但CPB期胰岛素敏感性指数明显低于CPB前。结论 :CPB期应激激素和血糖明显增高 ,胰岛素抵抗加重 ,并且这些变化随应激刺激的加强而加强 ,CPB期胰腺 β细胞分泌功能并未被抑制。 Objective:Anesthesia,surgery and cardiopulmonary bypass (CPB) are conventionally considered the major stress factors in the hormonal and metabolic responses to cardiac surgery.This study was to determine the influence of CPB on hormones,carbohydrate metabolism and insulin resistance.Methods:Blood samples were obtained from 19 patients at the following intervals:(1)before anesthesia(2)before CPB(3) 15 min after begining of CPB(4)5min after declamping of aorta(5)20min after CPB.Insulin,C-peptide,cortisol,growth hormone and blood glucose were measured.The ratio of insulin to glucose in blood(I/G) and insulin-sensitivity index [1/(I×G)] were obtained.Results:Insulin,growth hormone and cortisol were higher during and after CPB than that before CPB.Similar changes in levels of blood glucose,I/G and C-peptide were also observed,even though there was a significant decrease of insulin-sensitivity index.Conclusion:There are an obvious increase of concentrations in stress hormones and blood glucose and an aggravation of insulin resistance.All changes above do reflect the degree of surgical stress.The secretion of pancreatic beta cells is not suppressed during and after CPB.It is suggested that insulin supplement therapy may be beneficial to improve insulin resistance in the period of CPB.
作者 王萍 房秀生
出处 《重庆医科大学学报》 CAS CSCD 2004年第5期684-686,共3页 Journal of Chongqing Medical University
关键词 体外循环 胰岛素抵抗 激素 胰腺Β细胞 Cardiopulmonary bypass Insulin resistance Hormone Pancreatic beta cells
  • 相关文献

参考文献8

  • 1Moiler DE, Flier J S. Insulin resistance - mechanisms, syndromes, and implications[J]. N Engl J Med, 1991; 325:938 -948.
  • 2Schoenle E J, Qin - Ren Q, Zachmann M. Growth hormone requirement for a normal human adipocyte glucose carrier function[J]. J Clin Endocri Metabol, 1990 ;70:1674 - 1677
  • 3Lang CH, Bagby G J, Blakesley HL, et al. Importance of hyperglucagonemia in eliciting the sepsis- induced increase in glucose production[J]. Circulatory Shock, 1989; 29:181 - 191.
  • 4Weissman C. The metabolic response to stress: An overview and update[J]. Anesthesiology, 1990 ;73:308 - 327.
  • 5Brandi LS,Santoro D,Natali A,et al. Insulin resistance of stress: sites and mechanism[J]. Clin Sci, 1993; 85: 525 - 535.
  • 6Goudon EE. Hyperglycemic hyperosmolar syndrome [J].Am J Med Sci, 1976;271:252 - 268.
  • 7Brandi LS, Frediani M, Oleggini M, et al. Insulin resistance after surgery: normalization by insulin treatment[J]. Clin Sci, 1990; 79: 443 - 450.
  • 8Ljungqvist O, Thorell A, Gurniak M, et al. Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance[ J ]. J Am Coll Surg, 1994; 178: 329 - 335.

同被引文献34

  • 1Verma S, Maitland A, Weisel R D, et al. Hyperglycemia exaggerates ischemia- reperfusion-induced cardiomyocyte injury: reversal with endot helin antagonism[J]. J Thorac Cardiovasc Surg,2002,123(6): 1120-1124.
  • 2Turina M, Fry D E, Polk H C J. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects[J]. Crit Care Med, 2005, 33(7): 1624-1633.
  • 3Vanhorebeek I, De Vos R, Mesotten D, ct al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients[J]. The Lancet, 2005,365 (9453): 53-59.
  • 4Gross E R, LaDisa J F J, Weihrauch D, et al. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia[J].Am J Physiol Heart Circ Physiol, 2003,284(5 ): H1552-H1559.
  • 5Siroen M P, van Leeuwen P A, Nijveldt R J, et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment : a possible explanation of reduced morbidity and mortality[J]? Crit Care Med, 2005, 33 ( 3 ) : 504-510.
  • 6Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopuhnonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery[J]. J Thorac Cardiovasc Surg, 2005, 130(4):1144.
  • 7Ascione R, Rogers C A, Rajakaruna C, et al. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery[J]. Circulation, 2008, 118(2):113-123.
  • 8Lecomte P, Van Vlem B, Coddens J, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients[J].Crit Care,2008,12(6) : 154.
  • 9Furnary A P, Gao G, Grunkemeier G L, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting[J]. J Thorac Cardiovasc Surg, 2003,125 (5) : 1007- 1021.
  • 10Yates A R, Dyke P C, Taeed R, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient[J]. Pediatr Crit Care Med, 2006, 7 (4) : 351-355.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部